CDC Newsroom Archive

This page is a historical archive and is no longer maintained.

For current information, please visit http://www.cdc.gov/media/

Press Release

For Immediate Release: September 22, 2000
Contact: CDC Media Relations (404) 639-3286

MMWR Surveillance Summaries: September 22, 2000/Vol. 49/No. 9

Surveillance for Vaccination Coverage Among Children and Adults - United States

  1. National, State, and Urban Area Vaccination Coverage Levels Among Children Aged 19--35 Months United States, 1998

    On the basis of National Immunization Survey data, national coverage was greater than or equal to 90% for 3 doses of poliovirus vaccine, 3 doses of Haemophilus influenzae type b vaccine, and 1 dose of measles-containing vaccine. Coverage was the highest ever reported for 4 doses of any diphtheria and tetanus toxoids and pertussis vaccine, or diphtheria and tetanus toxoids and acellular pertussis vaccine (83.9%); 3 doses of hepatitis B vaccine ( 87.0%), and 1 dose of varicella vaccine (43.2%).
  2. Vaccination Coverage Among Children Enrolled in Head Start Programs or Day Care Facilities or Entering School

    CDC's National Immunization Program administers grants to support 64 vaccination programs. These programs are in all 50 states, 8 territories or jurisdictions, 5 cities (Chicago, Houston, San Antonio, New York City, and Philadelphia), and the District of Columbia. Grant guidelines require annual school vaccination surveys and biennial surveys of Head Start programs and licensed day care facilities. This system constitutes the only source of nationally representative vaccination coverage estimates for these populations.
  3. Influenza, Pneumococcal, and Tetanus Toxoid Vaccination of Adults - United States, 1993-1997

    In 1995, among adults 65 years of age and older, 58% reported receiving an influenza vaccination during the previous 12 months, and 34% reported ever receiving a pneumococcal vaccination. In 1995, the proportion of adults who reported receiving a tetanus vaccination during the previous 10 years decreased with age, from 65% among those 18-49 years to 54% among those 50-64 years. In each age group, women were less likely than men to report receiving tetanus toxoid.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

View Press Releases in
  • Español (Spanish)
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO